MedPath

Evaluation of the effect of coenzyme Q10 in oxidative stress

Phase 2
Conditions
Depression phase of bipolar disorder.
Bipolar affective disorder, current episode mild or moderate depression
Registration Number
IRCT2017022722965N7
Lead Sponsor
Vice Chancellor for research of Hamadan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
74
Inclusion Criteria

patients between 18-65 years old; patients with diagnosed bipolar depression based on DSM-5 and MADRS score equal to or more than 7
exclusion criteria:Death patients;Lack of cooperation patients by the end of the study;patients who intensified disease And not be able to continue cooperating

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
DNA damage,catalase activity,total antioxidant capacity. Timepoint: before the intervention,at the 8th week of intervention. Method of measurement: salivary & urine level.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath